Leucovorin tablets/Capsule bulk supplier for pharma manufacturers

Leucovorin Tablets/Capsule Suppliers & Bulk Manufacturers

Available Forms: Tablet/Capsules

Available Strengths: 15 mg, 50 mg

Reference Brands: Folvite(US & EU)

Category: Blood Disorder

Leucovorin tablets/Capsule is available in Tablet/Capsules and strengths such as 15 mg, 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Leucovorin tablets/Capsule is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Leucovorin tablets/Capsule can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Leucovorin tablets, marketed as Folvite, are approved in both the US by the FDA and in the EU via EMA for folate supplementation, chemotherapy support, and toxicity mitigation. Regulatory approval requires a comprehensive dossier including manufacturing details, clinical efficacy, safety data, and pharmacovigilance plans. In the US, FDA review involves detailed assessment of clinical and manufacturing information, while the EMA ensures compliance with regional standards. For expert guidance on dossier preparation, regulatory strategies, and market access, visit PharmaTradz. Ensuring regional compliance is vital for the safe and effective use of leucovorin tablets worldwide, supporting optimal patient outcomes in oncology and folate deficiency management.

Frequently Asked Questions

Yes, Leucovorin tablets/Capsule is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Leucovorin tablets/Capsule is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder

Strength: 500 units, 1000 units, and 2500 units

Form: Lyophilized Powder (Reconstituted for IV infusion)

Reference Brands: FEIBA(US)

View Details
Prothrombin Complex Concentrate (Pcc) Injection

Strength: 250 IU to 300 IU

Form: Injection

Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)

View Details
Mesna Injection

Strength: 100 mg/mL

Form: Injection

Reference Brands: Mesnex(US)

View Details
Pegfilgrastim Injection

Strength: 6 mg per single-use syringe

Form: Injection

Reference Brands: Neulasta, Pelgraz(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.